Clinical Trial

Effect of Renal Denervation on Bood Pressure in Patients on Hemodialysis

Study acronym: RDN-HD
Recruiting
View on ClinicalTrials.gov →
Summary
The RDN-HD Study is a prospective, single-center feasibility study. All patients included will undergo endovascular ultrasound-based RDN (no sham group, no blinding). The purpose of the RDN-HD Study is to demonstrate that ultrasound-based RDN is safe in patients with TRH and ESRD hemodialysis and reduces 24-h ambulatory BP.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-08-13.
Trial Details
NCT Number NCT06556407
Lead Sponsor University of Erlangen-Nürnberg Medical School
Conditions Treatment Resistant Hypertension, Chronic Hemodialysis
Enrollment 12 participants
Start Date 2024-03-04
Primary Completion 2026-12-01 (estimated)
Study Completion 2026-12-01 (estimated)
Updated on ClinicalTrials.gov 2025-09-26